Research Article
Modeling and Analysis of COVID-19 Spread: The Impacts of Nonpharmaceutical Protocols
Table 3
Values of biological parameters used in simulations of the COVID-19 model in Egypt 2020.
| | Parameters | Biological interpretation | Value (unit) | Reference |
| | Total human population size | 102,334,404 (individual) | [32] | | Per capita death rate (inverse of life expectancy) | (1/day) | [32] | | Recruitment rate of people | (1/day) | Estimated | | COVID-19-induced mortality rate in class | (1/day) | Fitted | | Effective transmission rate of infection from asymptomatic individuals | | Fitted | | Proportion of quarantine effect on effective contact rate | | Fitted | | Hospitalization rate of symptomatic individuals | (1/day) | Fitted | | Proportion of asymptomatically infected cases after the incubation period | | Fitted | | Average incubation period of coronavirus | (day) | Fitted | | Recovery rate from quarantined individuals | (1/day) | Fitted | | Rate of recovery for asymptomatic individuals | (1/day) | Fitted | | Recovery rate from symptomatic individuals | (1/day) | Fitted | | Rate of recovery for hospitalized patients | (1/day) | Fitted | | Quarantine rate of exposed individuals | (1/day) | Fitted | | Virus transmission coefficient | (1/day) | Fitted | | Rate of hospitalization from quarantined infected populations | (1/day) | Fitted | | COVID-19-induced mortality rate in class | (1/day) | Fitted | | COVID-19-induced death rate in class | (1/day) | Fitted |
|
|
